Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities
Net loss	$ (17,352,073)	$ (5,671,470)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	624,653	573,918
Non-cash interest expense including beneficial conversion	1,598,312	84,168
Bad debt expense	0	4,000
Recovery of bad debt	0	(8,400)
Deferred tax benefit	(129,095)	0
Stock compensation expense	1,445,088	64,412
Inventory obsolescence expense	0	21,877
Change in fair value of derivative financial instruments	647,342	0
Other non-cash items	24,010	14,681
Changes in operating assets and liabilities:
Accounts receivable	359,298	(257,686)
Inventory	424,505	(215,906)
Other assets	(319,305)	76,554
Accounts payable	196,444	198,177
Accrued compensation and other liabilities	(1,508,937)	(99,310)
Deferred revenue	(288,246)	(170,557)
Net cash used in operating activities	(14,278,004)	(5,385,542)
Cash flows from investing activities
Cash acquired in business combination	1,367,211	0
Purchases of property and equipment	(185,296)	(39,537)
Net cash provided by (used in) investing activities	1,181,915	(39,537)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of issuance costs	0	1,937,902
Proceeds from issuance of common stock, net of issuance costs	17,366,620	0
Proceeds from issuance of convertible notes, net of issuance costs	1,388,815	1,472,386
Proceeds from issuance of promissory notes, net of issuance costs	1,741,667	1,488,229
Proceeds from exercise of stock options and warrants	2,293	8
Payments on debt	(155,000)	(5,000)
Payments on capital lease obligations	(175,317)	(105,881)
Deferred IPO issuance costs	0	(13,393)
Net cash provided by financing activities	20,169,078	4,774,251
Effects of exchange rates on cash	(8,286)	0
Net increase (decrease) in cash and cash equivalents	7,072,989	(650,828)
Cash and cash equivalents at beginning of year	749,517	1,400,345
Cash and cash equivalents at end of year	7,814,220	749,517
Supplemental disclosure of cash flow information
Cash paid during the year for interest	194,288	32,296
Supplemental disclosure of noncash investing and financing activities:
Common stock issued for business combination	2,584,090	0
Acquisition of equipment purchased through capital leases and leasehold improvement allowances	580,477	0
Deferred and accrued IPO issuance costs	0	282,648
Convertible Debt [Member]
Supplemental disclosure of noncash investing and financing activities:
Debt Conversion, Converted Instrument, Amount	300,000	0
IPO [Member]
Supplemental disclosure of noncash investing and financing activities:
Debt Conversion, Converted Instrument, Amount	2,100,000	0
Series A Preferred Stock [Member]
Supplemental disclosure of noncash investing and financing activities:
Debt Conversion, Converted Instrument, Amount	3,000,000	0
Conversion of Series A preferred stock into common shares	$ 8,183,661	$ 0